期刊
JOURNAL OF PERSONALIZED MEDICINE
卷 13, 期 9, 页码 -出版社
MDPI
DOI: 10.3390/jpm13091416
关键词
hypertensive disorders; pregnancy-induced; Lipoprotein(a); Apolipoprotein B; cardiovascular diseases; pregnancy complications; biomarkers
This research investigates the association between altered lipid profiles and hypertensive disorders of pregnancy (HDP). The study finds significant elevations in Apolipoprotein B (ApoB) and Lipoprotein(a) (Lp(a)) levels in pregnant women with HDP, emphasizing the importance of early detection and specialized handling of cardiovascular risks in expectant mothers.
Background: This research delves into the association between altered lipid profiles and hypertensive disorders of pregnancy (HDP), shedding light on cardiovascular implications in maternal health. Methods: A cohort of 83 pregnant women was studied, with 48.19% diagnosed with HDP. This investigation primarily focused on Apolipoprotein B (ApoB) and Lipoprotein(a) (Lp(a)) as indicators of cardiovascular health. A comparative examination was conducted to determine discrepancies in the ApoB and Lp(a) levels between standard pregnancies and those presenting with HDP. Results: Significant elevations in ApoB (p value = 0.0486) and Lp(a) (p value < 0.0001) levels were observed in pregnant women with HDP compared to their counterparts with typical pregnancies. The pronounced link between heightened ApoB and Lp(a) concentrations and HDP persisted, even considering pregnancy's distinct physiological conditions. Conclusions: Our research accentuates the crucial role of early detection and specialized handling of cardiovascular risks in expectant mothers, especially those predisposed to HDP. The study indicates ApoB and Lp(a)'s potential as reliable markers for gauging cardiovascular threats during gestation. Furthermore, our findings suggest an integrative care approach and guidance for pregnant women, aspiring to enhance cardiovascular health in the postpartum phase.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据